Fiduciary Family Office LLC Invests $636,000 in The Clorox Company (NYSE:CLX)

Fiduciary Family Office LLC acquired a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 3,907 shares of the company's stock, valued at approximately $636,000.

Several other hedge funds have also recently made changes to their positions in CLX. First Foundation Advisors bought a new position in shares of Clorox in the first quarter worth approximately $31,000. Innealta Capital LLC bought a new position in shares of Clorox during the second quarter worth $30,000. Trifecta Capital Advisors LLC lifted its position in Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock valued at $30,000 after purchasing an additional 130 shares during the last quarter. Quarry LP lifted its position in Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company's stock valued at $31,000 after purchasing an additional 114 shares during the last quarter. Finally, Family Firm Inc. bought a new position in Clorox during the second quarter valued at $31,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares of the company's stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.57% of the company's stock.

Clorox Trading Down 0.0 %

CLX traded down $0.06 during mid-day trading on Tuesday, hitting $162.42. 1,134,838 shares of the stock were exchanged, compared to its average volume of 1,243,289. The firm's fifty day moving average is $161.63 and its two-hundred day moving average is $146.33. The Clorox Company has a 1-year low of $125.46 and a 1-year high of $169.09. The company has a market cap of $20.10 billion, a PE ratio of 56.61, a PEG ratio of 3.11 and a beta of 0.41. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. Clorox's revenue was up 27.0% compared to the same quarter last year. During the same period last year, the business posted $0.49 earnings per share. Equities analysts forecast that The Clorox Company will post 6.81 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.00%. The ex-dividend date is Wednesday, October 23rd. Clorox's dividend payout ratio (DPR) is presently 170.03%.

Wall Street Analyst Weigh In

Several research firms have commented on CLX. Jefferies Financial Group upgraded shares of Clorox from a "hold" rating to a "buy" rating and increased their price objective for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Evercore ISI reduced their target price on shares of Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a research note on Monday, October 14th. TD Cowen began coverage on Clorox in a report on Tuesday, July 23rd. They set a "sell" rating and a $122.00 price objective for the company. Citigroup increased their price objective on shares of Clorox from $165.00 to $170.00 and gave the company a "neutral" rating in a research report on Friday, September 6th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of Clorox from $144.00 to $151.00 and gave the company a "hold" rating in a research note on Friday, August 2nd. Six investment analysts have rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, Clorox has a consensus rating of "Hold" and a consensus price target of $151.57.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.